These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33431720)

  • 1. Effects of Prolonged Dual Antiplatelet Therapy in ST-Segment Elevation vs. Non-ST-Segment Elevation Myocardial Infarction.
    Kim J; Song YB; Oh JH; Cho DK; Lee JB; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC; Doh JH; Hahn JY;
    Circ J; 2021 May; 85(6):817-825. PubMed ID: 33431720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Hahn JY; Song YB; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Kim J; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC;
    Lancet; 2018 Mar; 391(10127):1274-1284. PubMed ID: 29544699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Kedhi E; Delewi R; Fabris E; De Luca G; Hermanides RS; van den Ent M; Buszman P; Zijlstra F; Song YB; Gwon HC; Hahn JY
    Atherosclerosis; 2020 Dec; 315():55-61. PubMed ID: 33227548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction.
    Lee SJ; Cho JY; Kim BK; Yun KH; Suh Y; Cho YH; Kim YH; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon HM; Hong SJ; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
    JACC Cardiovasc Interv; 2021 Feb; 14(4):431-440. PubMed ID: 33602439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
    Kedhi E; Fabris E; van der Ent M; Kennedy MW; Buszman P; von Birgelen C; Cook S; Wedel H; Zijlstra F
    Am Heart J; 2017 Jun; 188():11-17. PubMed ID: 28577666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
    Danchin N; Puymirat E; Cayla G; Cottin Y; Coste P; Gilard M; Goldstein P; Braun F; Belle L; Montalescot G; Ferrières J; Schiele F; Simon T;
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007241. PubMed ID: 30354592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
    Saito T; Fujisaki T; Aikawa T; Kampaktsis PN; Malik A; Briasoulis A; Takagi H; Wiley J; Slipczuk L; Kuno T
    Int J Cardiol; 2023 Oct; 389():131157. PubMed ID: 37433404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia.
    Zou Y; Yang S; Wang S; Lv B; Xiu L; Li L; Lee SW; Chin CT; Pocock SJ; Huo Y; Yu B
    Clin Cardiol; 2020 Apr; 43(4):346-354. PubMed ID: 31967663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Chronic Antiplatelet Therapy on Infarct Size and Bleeding in Patients With Acute Myocardial Infarction.
    Campodonico J; Cosentino N; Milazzo V; Rubino M; De Metrio M; Marana I; Moltrasio M; Grazi M; Lauri G; Bonomi A; Veglia F; Chiorino E; Assanelli E; Bartorelli AL; Marenzi G
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):407-413. PubMed ID: 29669424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    Smits PC; Frigoli E; Vranckx P; Ozaki Y; Morice MC; Chevalier B; Onuma Y; Windecker S; Tonino PAL; Roffi M; Lesiak M; Mahfoud F; Bartunek J; Hildick-Smith D; Colombo A; Stankovic G; Iñiguez A; Schultz C; Kornowski R; Ong PJL; Alasnag M; Rodriguez AE; Paradies V; Kala P; Kedev S; Al Mafragi A; Dewilde W; Heg D; Valgimigli M;
    J Am Coll Cardiol; 2022 Sep; 80(13):1220-1237. PubMed ID: 36137672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.
    Giacoppo D; Matsuda Y; Fovino LN; D'Amico G; Gargiulo G; Byrne RA; Capodanno D; Valgimigli M; Mehran R; Tarantini G
    Eur Heart J; 2021 Jan; 42(4):308-319. PubMed ID: 33284979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Kedhi E; Verdoia M; Suryapranata H; Damen S; Camaro C; Benit E; Barbieri L; Rasoul S; Liew HB; Polad J; Ahmad WA; Zambahari R; Lalmand J; van der Schaaf RJ; Koh TH; Timmermans P; Dilling-Boer D; Veenstra LF; Van' T Hof AW; Lee SW; Roolvink V; Ligtenberg E; Postma S; Kolkman EJ; Brouwer MA; Dudek D; De Luca G
    Atherosclerosis; 2021 Mar; 321():39-44. PubMed ID: 33639478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.
    Gamal AS; Hara H; Tomaniak M; Lunardi M; Gao C; Ono M; Kawashima H; Jüni P; Vranckx P; Windecker S; Hamm C; Steg PG; Onuma Y; Serruys PW
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):756-773. PubMed ID: 34212187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
    Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.
    Kedhi E; Fabris E; van der Ent M; Buszman P; von Birgelen C; Roolvink V; Zurakowski A; Schotborgh CE; Hoorntje JCA; Eek CH; Cook S; Togni M; Meuwissen M; van Royen N; van Vliet R; Wedel H; Delewi R; Zijlstra F
    BMJ; 2018 Oct; 363():k3793. PubMed ID: 30279197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
    Costa F; Vranckx P; Leonardi S; Moscarella E; Ando G; Calabro P; Oreto G; Zijlstra F; Valgimigli M
    Eur Heart J; 2015 May; 36(20):1242-51. PubMed ID: 25718355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Value of PRECISE-DAPT Score for In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tanik VO; Cinar T; Arugaslan E; Karabag Y; Hayiroglu MI; Cagdas M; Rencuzogullari I; Uluganyan M
    Angiology; 2019 May; 70(5):440-447. PubMed ID: 30322265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.